ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve CLL or SLL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02264574
Recruitment Status : Active, not recruiting
First Posted : October 15, 2014
Last Update Posted : January 6, 2017
Sponsor:
Information provided by (Responsible Party):
Pharmacyclics LLC.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2017
  Estimated Study Completion Date : January 2020